Risk and Protective Factors in Multimodal Pain Therapy in Patients With Chronic Lumbal Pain
NCT ID: NCT04881188
Last Updated: 2022-05-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2023-01-31
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Three main aims are: 1. Prospective validation of a short screening on a theoretical basis for the collection of psychosocial risk factors concerning of an unfavourable therapeutic process in MPT. 2. the verification of differences in subgroups with regard to pain management on a basis of the Avoidance Endurance Model in the development of pain and pain-related disability. 3. The evaluation of potential psychosocial protective factors supporting a positive outcome of MPT, such as resilience, acceptance, self-compassion, and body image.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Multimodal Pain Therapy in Patients With Mixed Chronic Pain Syndromes
NCT01346202
Conditioned Pain Modulation in Localized vs Widespread Chronic Low Back Pain
NCT05972395
Nociplastic Pain Symptoms and Sensory Profiles in Low Back Pain
NCT05592405
The Association Between Conditioned Pain Modulation and Pain Catastrophizing in Chronic Low Back Pain
NCT03644810
Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders
NCT04907162
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For the diagnosis of the different pain pattern postulated by the AEM, the 9-item Avoidance Endurance Fast-Screen (AEFS) is a reliable and valid short screening. However, it has been investigated in patients with acute pain, so far. A separate validation for patients with CLPB is necessary. Our working group wants to tie up the planned prospective study to preliminary work and show for the first time processes of patients with CLBP undergoing MPT.
On a theoretical basis results will be informative about possible protective factors being important for recovery. On a clinically applied basis we plan the validation of a short-screening of psychosocial risk- and protective factors in patients with CLBP undergoing MPT.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with chronic low back pain
Patients suffering from chronic low back pain (duration longer than 3 months) undergoing a multimodal pain therapy
Survey
Patients with chronic low back pain in in-patient multimodal pain therapy. Three survey times, questionnaires
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Survey
Patients with chronic low back pain in in-patient multimodal pain therapy. Three survey times, questionnaires
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* acute fractures
* pregnancy
* neurological dieases
* psychiatric diseases
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Katholisches Klinikum Bochum
UNKNOWN
Ruhr University of Bochum
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Claudia Levenig
Researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tobias L Schulte, Prof.
Role: STUDY_CHAIR
Katholisches Klinikum Bochum
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Katholisches Klinikum, Klinik Blankenstein
Hattingen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MST2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.